Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
Mayo Clinic, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 6
Mayo Clinic, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 7
Mayo Clinic, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 8
Mayo Clinic, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 9
Mayo Clinic, Medical Devices Deals, 2011 to YTD 2017 10
Mayo Clinic, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 11
Mayo Clinic, Pharmaceuticals & Healthcare, Deal Details 13
Venture Financing 13
Qrativ Raises USD8.3 Million in Series A Financing 13
Evelo Biosciences Raises USD50 Million in Series B Financing 14
DayTwo Secures USD12 Million in Series A Funding 15
DayTwo Raises USD12 Million in Series A Financing 16
Second Genome Raises USD42.6 Million in Series B Financing 17
Unity Biotechnology Raises Funds in Venture Financing 19
AssureRx Health Raises Additional USD15 Million in Series D Financing 20
Partnerships 21
Mayo Clinic and nference Form Joint Venture 21
Baxter International and Mayo Clinic Enter into Research Agreement 22
Evelo Biosciences Enters into Research Agreement with Mayo Clinic 23
EnBiotix Partners with Mayo Clinic 24
Inovio Pharma Partners with National Cancer Institute and Mayo Clinic 25
GE Ventures Forms Joint Venture with Mayo Clinic 26
Morphotek Enters into Agreement with Mayo Clinic 27
Licensing Agreements 28
Evelo Biosciences Enters into Licensing Agreement with Mayo Clinic 28
Mayo Clinic Enters into Licensing Agreement with ID Pharma 29
TapImmune Exercises Option for Licensing Agreement with Mayo Clinic for HER2/neu Vaccine Technology 30
PsychoGenics Enters Into Licensing Agreement With Mayo Clinic And TET Systems For rTg4510 Tauopathy Mouse Model 31
Zumbro Discovery Enters into Licensing Agreement with Mayo Clinic 32
Mayo Clinic – Key Competitors 33
Mayo Clinic – Key Employees 34
Mayo Clinic – Locations And Subsidiaries 35
Head Office 35
Other Locations & Subsidiaries 35
Joint Venture 36
Recent Developments 37
Strategy And Business Planning 37
Jul 14, 2017: Mayo Clinic, nference Launch a Startup to Discover, Develop Treatments for Diseases with Unmet Medical Need 37
Research And Development 39
Dec 13, 2016: Tyme Technologies Announces Launch of a Pancreatic Research Program with the Mayo Clinic Led by Dr. Martin Fernandez-Zapico 39
Legal and Regulatory 40
Jul 27, 2016: Updated Testing Guidelines Make More Women Eligible for Herceptin, yet Benefit Uncertain 40
Government and Public Interest 41
Nov 01, 2017: New Study Links Severe Hot Flashes With Greater Risk of Obstructive Sleep Apnea 41
Oct 24, 2017: Proton therapy may be better option for elderly patients with esophageal cancer 42
Sep 25, 2017: Halving radiation therapy for HPV-related throat cancer offers fewer side effects, similar outcomes 43
Sep 18, 2017: Scientists Discover Novel Mechanism Underlying ALS and Related Dementia 44
Aug 29, 2017: Study finds hormone therapy improves sleep quality for recently menopausal women 45
Aug 25, 2017: Study identifies genes linked to better immune response to flu vaccine 46
May 02, 2017: Mayo Clinic researchers develop new tumor-shrinking nanoparticle to fight cancer, prevent recurrence 47
Jan 09, 2017: Mayo Clinic researchers identify new potential treatment for cancer metastasis 48
Sep 15, 2016: Mayo receives federal grant to test innovative triple-negative breast cancer vaccine 49
Jul 27, 2016: Gene therapy for metabolic liver diseases shows promise in pigs 50
Jul 25, 2016: Scientists Test Ways to Discuss Opioid Risks With ER Patients 51
Jul 06, 2016: NIH awards $55 million to build million-person precision medicine study 52
Jun 14, 2016: Mayo Clinic researchers develop accurate way to measure growth factor linked to aging 54
May 05, 2016: Protein may Predict Response to Immunotherapy in Patients with Metastatic Melanoma 55
May 04, 2016: $7 Million Research Funding Award for Migraine Research 56
Apr 01, 2016: TGen and Mayo Clinic scientists issue report in Cell on advances in basal cell carcinoma treatment 57
Mar 29, 2016: Researchers investigate four promising new treatments for Lyme disease 58
Mar 04, 2016: Reducing Variability in Spirometry Testing for Clinical Trials, New Webinar Hosted by Xtalks 60
Feb 18, 2016: Surgery and stenting safe, effective lowering long-term risk of stroke 61
Feb 11, 2016: Long-term benefits of ‘senolytic’ drugs on vascular health in mice 62
Feb 08, 2016: New Lyme-disease-causing bacteria species discovered 63
Product News 65
Nov 20, 2017: New oral anticoagulant drugs associated with lower kidney risks, Mayo Clinic research shows 65
Nov 16, 2016: Next-generation biomaterial being developed to treat bleeding 67
Nov 01, 2017: Mayo Clinic researchers find genetic pathways to individualized treatment for advanced prostate cancer 68
Aug 22, 2016: Mayo Clinic researchers investigate protein’s role in cell division 69
May 03, 2017: Mayo Clinic-invented technologies show brain tumor firmness, adhesion before surgery 70
Jan 04, 2016: Mayo Clinic researchers reduce stem cell dysfunction and metabolic disease in aged mice 71
Appendix 72
Methodology 72
About GlobalData 72
Contact Us 72
Disclaimer 72
Mayo Clinic, Pharmaceuticals & Healthcare, Key Facts, 2015 2
Mayo Clinic, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 6
Mayo Clinic, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 7
Mayo Clinic, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 8
Mayo Clinic, Deals By Therapy Area, 2011 to YTD 2017 9
Mayo Clinic, Medical Devices Deals, 2011 to YTD 2017 10
Mayo Clinic, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 11
Qrativ Raises USD8.3 Million in Series A Financing 13
Evelo Biosciences Raises USD50 Million in Series B Financing 14
DayTwo Secures USD12 Million in Series A Funding 15
DayTwo Raises USD12 Million in Series A Financing 16
Second Genome Raises USD42.6 Million in Series B Financing 17
Unity Biotechnology Raises Funds in Venture Financing 19
AssureRx Health Raises Additional USD15 Million in Series D Financing 20
Mayo Clinic and nference Form Joint Venture 21
Baxter International and Mayo Clinic Enter into Research Agreement 22
Evelo Biosciences Enters into Research Agreement with Mayo Clinic 23
EnBiotix Partners with Mayo Clinic 24
Inovio Pharma Partners with National Cancer Institute and Mayo Clinic 25
GE Ventures Forms Joint Venture with Mayo Clinic 26
Morphotek Enters into Agreement with Mayo Clinic 27
Evelo Biosciences Enters into Licensing Agreement with Mayo Clinic 28
Mayo Clinic Enters into Licensing Agreement with ID Pharma 29
TapImmune Exercises Option for Licensing Agreement with Mayo Clinic for HER2/neu Vaccine Technology 30
PsychoGenics Enters Into Licensing Agreement With Mayo Clinic And TET Systems For rTg4510 Tauopathy Mouse Model 31
Zumbro Discovery Enters into Licensing Agreement with Mayo Clinic 32
Mayo Clinic, Key Competitors 33
Mayo Clinic, Key Employees 34
Mayo Clinic, Other Locations 35
Mayo Clinic, Subsidiaries 35
Mayo Clinic, Joint Venture 36